Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1241 of 6351
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis phase I trial studies the side effects and best dose of BSB-2002 when given after cyclophosphamide and fludarabine and tests how well it works in treating NPM1-mutated acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or that does not r…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New ECMO technique aims to bridge lung transplant patients safely to surgery
Disease control Recruiting nowThe purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-RVF) patients to lung transplant safely.
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo aims to tame aggressive lymphoma in frail patients
Disease control Not yet recruitingThis phase I trial tests the safety, side effects and best dose of epcoritamab alone and epcoritamab with polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R- mini-CHP) for the treatment of diffuse large B cell lymphoma (DLBCL) in elderly or unfi…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Personalized cell therapy takes on Hard-to-Treat tumors
Disease control Not yet recruitingThis study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with advanced solid tumors. Autologous TILs and gene-edited TILs are expanded from tumor resections and infused i.v. into the patient after NMA lymphodepletion treatmen…
Phase 1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could 5 days of radiation replace 25 for sarcoma patients?
Disease control Not yet recruitingThis clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to standard-course radiation therapy over 25 days (RT-25) in treating patients with soft tissue sarcomas of the extremities that may be primary or that may have co…
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New mRNA vaccine aims to shield against RSV
Vaccine Not yet recruitingThe study will evaluate the safety, tolerability, and immunogenicity of a single injection of up to 4 dose levels of IN006 in younger adults and 3 dose levels of IN006 in older adults; of a revaccination of IN006 given approximately 12 months after the initial vaccination in olde…
Phase 1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 12:06 UTC
-
Could a simple spray prevent dangerous blood pressure spikes after spinal injury?
Prevention Not yet recruitingThis project aims to evaluate the safety and efficacy of using a short-acting drug to reduce the maximal blood pressure during dangerous blood pressure spikes that happen during bowel care in individuals with spinal cord injury. the investigators will monitor the physiological ef…
Phase 2 • Sponsor: Simon Fraser University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Heart drugs may boost recovery after valve surgery
Disease control Not yet recruitingThis trial aims to improve the heart health of people with a narrowed aortic valve called aortic stenosis (AS) who then have aortic valve replacement (AVR) by assessing the change in the mass of the left ventricle. Even after an AVR in many patients the heart is still unable to …
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New trial aims to slash deadly bloodstream infections from hospital tubes
Prevention Not yet recruitingThe IVCare trial is a multicentre adaptive platform study evaluating interventions to prevent infections and other complications associated with central venous access devices (CVADs) in patients with newly inserted or existing devices. The study is organised into domains addressi…
Sponsor: The University of Queensland • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Online group aims to lift depression in lewy body dementia caregivers
Symptom relief Not yet recruitingThis study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in family caregivers of people with Lewy Body Dementia (LBD), compared to standard educational materials. LBD is the second most common form of degenerative dementia …
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Smartphone app aims to uncover food triggers for gut cancer survivors
Symptom relief Not yet recruitingThere are two components to the study: a patient and a clinician study. The clinician study will include one-hour semi-structured interviews with oncology specialists to identify facilitators and barriers to integrating digital diet interventions into the clinical workflow, and t…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug and better measurement tools aim to tackle severe valley fever
Disease control Not yet recruitingThe purpose of this study is to test measurement tools (questionnaire about symptoms and a questionnaire about quality of life) to assess usability in the assessment of treatment effectiveness for people with disseminated coccidioidomycosis (DCM).
Phase 2 • Sponsor: F2G Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a simple ultrasound predict which newborns breathe on their own?
Knowledge-focused Not yet recruitingThis protocol proposes a prospective observational study to develop and validate such a model, directly addressing a critical evidence gap identified by recent systematic reviews.
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can reading a Preemie's cues speed up independent feeding?
Knowledge-focused CancelledIn this parallel-group randomized controlled trial, very low birthweight infants will be randomly assigned in a 1:1 ratio to either cue-based (intervention group) or clinician-driven feeding (control group). For infants in the intervention group, Speech therapists and nurses will…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can two antibodies free HIV patients from daily pills? early trial launches
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, and efficacy of combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Patient's own blood help heal deep gum pockets?
Disease control Not yet recruitingPeriodontitis is an inflammatory disease that damages the tissues supporting the teeth. Nonsurgical periodontal therapy is the standard initial treatment, but deep periodontal pockets may remain after treatment. Albumin platelet-rich fibrin (Alb-PRF) is an autologous material pre…
Sponsor: Halil Ata BIÇAKÇIOĞLU • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for nighttime cluster headaches: Low-Sodium drug enters trial
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy of low sodium oxybate (LXB) (brand name Xywav) in the treatment of (nocturnal) cluster headache attacks in subjects with chronic cluster headache. It is a 16 week, randomized, double-blind, placebo- controlled, bi-cente…
Phase 2 • Sponsor: Leiden University Medical Center • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Freezing out dead tissue: new tool could transform pancreatic necrosis treatment
Disease control Recruiting nowPancreatic necrosis is a serious complication of acute pancreatitis. Pancreatic necrosis involves the irreversible death of pancreatic tissue, which can lead to severe health issues, including infections and an increased risk of death. An endoscopic procedure called direct endosc…
Sponsor: Christopher C. Thompson, MD, MSc • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
School nurses to supervise asthma inhaler use in new trial
Disease control Not yet recruitingThe goal of this research trial is to: 1) Develop a SMART-SBAT protocol specifically designed for schools, 2) Evaluate the effectiveness of SMART-SBAT vs. usual care using a district wide, stepped-wedge type 1 cluster randomized trial and 3) Evaluate the process of implementing S…
Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New injection shrinks throat tumors before surgery?
Disease control Recruiting nowThe purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC